Fortress Biotech, Inc. (FBIOP) Free Cash Flow (2010 - 2025)

Fortress Biotech's Free Cash Flow history runs 16 years deep, the most recent figure standing at -$12.5 million for Q4 2025.

• In Q4 2025, Free Cash Flow rose 2.81% year-over-year to -$12.5 million; the TTM figure through Dec 2025 stood at -$65.8 million (up 17.97% YoY), while the FY2025 annual figure was -$65.8 million, up 17.97% from the prior year.
• Free Cash Flow for Q4 2025 stood at -$12.5 million, down from -$6.1 million in the prior quarter.
• The five-year high for Free Cash Flow was -$6.1 million in Q3 2025, with the low at -$50.5 million in Q4 2022.
• The 5-year median for Free Cash Flow is -$26.5 million (2024), against an average of -$28.9 million.
• The sharpest annual moves came in 2022 and 2025: Free Cash Flow slumped 116.78% in 2022, then surged 67.26% in 2025.
• Fortress Biotech's Free Cash Flow stood at -$40.7 million in 2021, then fell by 24.32% to -$50.5 million in 2022, then jumped by 30.82% to -$35.0 million in 2023, then surged by 63.08% to -$12.9 million in 2024, then increased by 2.81% to -$12.5 million in 2025.
• Business Quant data shows FBIOP's Free Cash Flow at -$12.5 million in Q4 2025, -$6.1 million in Q3 2025, and -$27.6 million in Q2 2025.